Gefticip Tablet

Gefticip Tablet – Gefitinib 250 mg for Non-Small Cell Lung Cancer

Gefticip Tablet is a targeted anti-cancer prescription medicine containing Gefitinib 250 mg, manufactured by Cipla Ltd. It is a tyrosine kinase inhibitor used in the treatment of non-small cell lung cancer (NSCLC), given alone or alongside other cancer medicines as part of a doctor-supervised treatment plan.

Key Features

• Contains Gefitinib 250 mg, a targeted EGFR tyrosine kinase inhibitor
• Used in the treatment of non-small cell lung cancer
• Manufactured by Cipla Ltd, a trusted pharmaceutical company
• Prescription-only (Rx) oncology medicine, bottle of 30 tablets
• May be used as monotherapy or in combination regimens

Composition

• Gefitinib – 250 mg

Uses & Benefits

• Treatment of non-small cell lung cancer (NSCLC)
• Works by blocking growth signals that drive cancer cell proliferation
• Can be used as a first-line or subsequent treatment as advised by an oncologist
• May be combined with other anti-cancer medicines for enhanced disease control
• Helps control tumour growth and manage disease progression under specialist care

Directions for Use

• Take strictly in the dose, frequency, and duration prescribed by your oncologist
• Swallow the tablet whole with water, generally at the same time each day
• Can be taken with or without food unless advised otherwise
• Avoid alcohol during treatment and drink plenty of water to stay hydrated
• Do not miss or double doses; contact your doctor if a dose is missed

Precautions

• To be sold strictly on the prescription of a Registered Medical Practitioner; this is a potent and toxic medicine
• Regular liver function and overall health monitoring is typically required during treatment
• Inform your doctor of any lung, liver, or eye conditions before starting therapy
• Common effects may include diarrhoea, skin rash, nausea, and loss of appetite – report severe or persistent symptoms promptly
• Not recommended during pregnancy or breastfeeding; effective contraception should be used as advised
• Discuss all other medicines and supplements you take, as interactions are possible

Storage

• Store below 30°C in a cool, dry place away from direct sunlight
• Keep out of reach and sight of children
• Keep the bottle tightly closed when not in use

Disclaimer: This product is a prescription oncology medicine. The information provided is for general awareness only and does not substitute professional medical advice. Please consult a Registered Medical Practitioner/oncologist before use.